سيسبح بحثة المحمولة لللتعابرة برئة المميت المميت على على الوقاح وقائي في العلم في الذهب المراد. However, it is the best advice to avoid smoking.
And the “Daily Mail” newspaper pointed out that researchers from the University of London College and the University of Oxford will lead this experiment, which will last four years, and it is expected that the first phase will begin in the summer of 2026.
search for the same thing
The team will focus in the first phase of the trial on determining the best dose of the “LangVax” vaccine (LungVax) for patients at high risk, in addition to checking the possible side effects of the various doses.
Cancer is the most common cancer worldwide and the main cause of cancer-related deaths. ويعقد العاملهم آلان على أن حافظوا من بدونة توفيد من كرنك باملة
Prof. Maryam Jamal Hanjani, the co-founder and leader of the experiment, commented: “less than 10% of people with lung cancer remain alive for ten years or more. This reality must change, and the change will be achieved by targeting lung cancer in its early stages.”
Warning about smoking
However, Prof. Hanjani warned that “preventive vaccinations are not the best way to reduce the risk of lung cancer, but they may provide an effective way to prevent some types of cancer in the first place.”
The vaccine is based on the antiretroviral virus (mRNA) technology, similar to that used in the Covid-19 vaccine. The vaccine works by training the immune system to distinguish the proteins found on the surface of abnormal lung cells, which are known as “antibodies to the virus”.
From her side, said Dr. Sarah Blaaghdan, who shared the LungVax project from Oxford University: “lung cancer is a fatal disease that destroys the lives of many. The chances of survival were very low for decades, and this vaccine is our opportunity to do something to prevent this disease effectively.”
details of the first experience
To ensure the effectiveness and safety of the vaccine, the patient will be diagnosed with lung cancer at an early stage and successfully treated, making them highly vulnerable to the return of the disease. The vaccine will also be given to patients participating in the program of cancer screening.
Dr. Hanjani concluded by saying: “The clinical trial of LungVax is the first and decisive step in introducing this vaccine to people who are most at risk of contracting the disease. It carefully prepares individuals to respond to the vaccine, and it is easy to administer it, and those who may benefit from it more in the future.”
And if the experiment is successful, the team hopes to expand the scope of the vaccine to include more individuals at risk of this fatal disease.
Also read:
6 common symptoms that indicate deaf cancer
5 habits of the night
للشاي الخدر 5 أضرار و4 categories prohibited من طانولة
عقلى برازيلية تتعملة اغلى بيتزا بالنمل.. فيديو يتير الدهشة
فلكية changes
اترك تعليقاً